Search - tctmd.com

Displaying 561 - 580 of 1086

Sort: Relevancy | Date

A secondary analysis from ASPREE sets up two large RCTs testing statins in an elderly primary-prevention population.

News Daily News

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Michael O'Riordan

July 06, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

Rural-Urban Gap Widens for Cardiometabolic Health Disparities

Michael O'Riordan

June 22, 2020

News Daily News

Most Stable Angina Patients Not Taking First-line Meds

Shelley Wood

June 18, 2020

News Daily News

YOUNG-MI: Quick EF Recovery Key to Cutting Deaths in Those Under 50

L.A. McKeown

June 04, 2020

News Daily News

AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives

Yael L. Maxwell

May 29, 2020

News Daily News

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Yael L. Maxwell

May 28, 2020

News Daily News

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Michael O'Riordan

May 15, 2020

News Daily News

High-Intensity Sport Post-COVID: Expert Advice From Sports Cardiologists

Caitlin E. Cox

May 13, 2020

News Daily News

New AHA Guidance on Hospital VTE Stresses Risk Assessment, Standardization

Yael L. Maxwell

May 12, 2020

News Daily News

Kawasaki Link to COVID-19 in Kids Probed as UK, New York Issue Alerts

Shelley Wood

May 06, 2020

News Daily News

Like Tobacco, Long-term E-Cigarettes Harm Vascular Function

Caitlin E. Cox

April 30, 2020

News Daily News

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Yael L. Maxwell

April 28, 2020

News Daily News

SMASH: Population-Based Sodium Reduction Sees Success in China

L.A. McKeown

April 28, 2020

News Features

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Michael O'Riordan

April 24, 2020

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Caitlin E. Cox

April 23, 2020

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

News Conference News ACC 2020

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Yael L. Maxwell

April 06, 2020

News Conference News ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

Todd Neale

April 02, 2020

Hope for these hard-to-treat patients: more than half saw ≥ 50% decrease at 24 weeks, regardless of LDL receptor function.

News Conference News ACC 2020

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Yael L. Maxwell

April 01, 2020

Advertisement

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Rural-Urban Gap Widens for Cardiometabolic Health Disparities

Most Stable Angina Patients Not Taking First-line Meds

YOUNG-MI: Quick EF Recovery Key to Cutting Deaths in Those Under 50

AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

High-Intensity Sport Post-COVID: Expert Advice From Sports Cardiologists

New AHA Guidance on Hospital VTE Stresses Risk Assessment, Standardization

Kawasaki Link to COVID-19 in Kids Probed as UK, New York Issue Alerts

Like Tobacco, Long-term E-Cigarettes Harm Vascular Function

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

SMASH: Population-Based Sodium Reduction Sees Success in China

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content